(Press-News.org) Arriving at a rapid and accurate diagnosis is critical during flu outbreaks, but until now, physicians and public health officials have had to choose between a highly accurate yet time-consuming test or a rapid but error-prone test.
A new detection method developed at the University of Georgia and detailed in the August edition of the journal Analyst, however, offers the best of both worlds. By coating gold nanoparticles with antibodies that bind to specific strains of the flu virus and then measuring how the particles scatter laser light, the technology can detect influenza in minutes at a cost of only a fraction of a penny per exam.
"We've known for a long time that you can use antibodies to capture viruses and that nanoparticles have different traits based on their size," said study co-author Ralph Tripp, Georgia Research Alliance Eminent Scholar in Vaccine Development in the UGA College of Veterinary Medicine. "What we've done is combine the two to create a diagnostic test that is rapid and highly sensitive."
Working in the UGA Nanoscale Science and Engineering Center, Tripp and co-author Jeremy Driskell linked immune system proteins known as antibodies with gold nanoparticles. The gold nanoparticle-antibody complex aggregates with any virus present in a sample, and a commercially available device measures the intensity with which the solution scatters light.
Driskell explained that gold nanoparticles, which are roughly a tenth of the width of a human hair, are extremely efficient at scattering light. Biological molecules such as viruses, on the other hand, are intrinsically weak light scatterers. The clustering of the virus with the gold nanoparticles causes the scattered light to fluctuate in a predictable and measurable pattern.
"The test is something that can be done literally at the point-of-care," said Driskell, who worked on the technology as an assistant research scientist in Tripp's lab. "You take your sample, put it in the instrument, hit a button and get your results."
Gold is often thought of as a costly metal, but the new diagnostic test uses such a small amount—less than what would fit on the head of the pin—that the cost is one-hundredth of a cent per test.
The researchers noted that the current standard for definitively diagnosing flu is a test known as PCR, for polymerase chain reaction. PCR can only be done in highly specialized labs and requires that specially trained personnel incubate the sample for three days, extract the DNA and then amplify it many times. The entire process, from sample collection to result, takes about a week and is too costly for routine testing.
The alternative is a rapid test known as a lateral flow assay. The test is cost effective and can be used at the point-of-care, but it can't identify the specific viral strain. It also misses up to 50 percent of infections and is especially error-prone when small quantities of virus are present, Driskell added.
By overcoming the weaknesses of existing diagnostic tests, the researchers hope to enable more timely diagnoses that can help halt the spread of flu by accurately identifying infections and allowing physicians to begin treatment early, when antiviral drugs, such as Tamiflu, are most effective.
Tripp and Driskell are planning to compare the new diagnostic test with another that Tripp and his colleagues developed that measures the change in frequency of a laser as it scatters off viral DNA or RNA. Tripp also is working to adapt the new technique so that poultry producers can rapidly detect levels of salmonella in bath water during processing. Poultry is the largest agricultural industry in Georgia, he pointed out, so the technology could have a significant impact on the state's economy.
"This test offers tremendous advantages for influenza, but we really don't want to stop there," Tripp said. "Theoretically, all we have to do is exchange our anti-influenza antibody out with an antibody for another pathogen that may be of interest, and we can do the same test for any number of infectious agents."
INFORMATION:
To learn more about the UGA Nanoscale Science and Engineering Center, see http://nano.uga.edu/. To learn more about the College of Veterinary Medicine, see http://www.vet.uga.edu/.
Note to editors: For a high-resolution image of Tripp, see http://www.photo.alumni.uga.edu/news/22041-022.jpg.
UGA researchers use gold nanoparticles to diagnose flu in minutes
2011-08-04
[Attachments] See images for this press release:
ELSE PRESS RELEASES FROM THIS DATE:
GEN reports on nanotechology's impact on mass spectrometry
2011-08-04
New Rochelle, NY, August 3, 2011—A move toward smaller and smaller sample sizes is leading to a new generation of mass spectrometry instrumentation, reports Genetic Engineering & Biotechnology News (GEN). From a specific application point of view, novel nanoflow separation methodologies are ramping up the speed and precision with which scientists are able to validate biomarkers, according to the August issue of GEN (www.genengnews.com/gen-articles/nanoliter-volumes-push-ms-to-new-lows/3741).
"Basing biomarker validation on more sophisticated mass spec tools could help ...
Researchers develop and test new molecule as a delivery vehicle to image and kill brain tumors
2011-08-04
RICHMOND, Va. (Aug. 3, 2011) – A single compound with dual function – the ability to deliver a diagnostic and therapeutic agent – may one day be used to enhance the diagnosis, imaging and treatment of brain tumors, according to findings from Virginia Commonwealth University and Virginia Tech.
Glioblastomas are the most common and aggressive brain tumor in humans, with a high rate of relapse. These tumor cells often extend beyond the well-defined tumor margins making it extremely difficult for clinicians and radiologists to visualize with current imaging techniques. Researchers ...
New study calls into question reliance on animal models in cardiovascular research
2011-08-04
Anyone who follows science has read enthusiastic stories about medical breakthroughs that include the standard disclaimer that the results were obtained in mice and might not carry over to humans.
Much later, there might be reports that a drug has been abandoned because clinical trials turned up unforeseen side effects or responses in humans. Given the delay, most readers probably don't connect the initial success and the eventual failure.
But Igor Efimov, PhD, a biomedical engineer at Washington University in St. Louis who studies the biophysical and physiological ...
Bellybutton microbiomes
2011-08-04
Public awareness about the role and interaction of microbes is essential for promoting human and environmental health, say scientists presenting research at the Ecological Society of America's (ESA) 96th Annual Meeting from August 7-12, 2011. Researchers shed light on the healthy microbes of the human body and other research on microbial and disease ecology to be presented at ESA's 2011 meeting in Austin, Texas.
Bellybutton microbiomes
Human skin is teeming with microbes—communities of bacteria, many of which are harmless, live alongside the more infamous microbes sometimes ...
Mold exposure during infancy increases asthma risk
2011-08-04
Infants who live in "moldy" homes are three times more likely to develop asthma by age 7—an age that children can be accurately diagnosed with the condition.
Study results are published in the August issue of Annals of Allergy, Asthma & Immunology, the scientific journal of the American College of Allergy, Asthma and Immunology (ACAAI).
"Early life exposure to mold seems to play a critical role in childhood asthma development," says Tiina Reponen, PhD, lead study author and University of Cincinnati (UC) professor of environmental health. "Genetic factors are also ...
US physicians spend nearly 4 times more on health insurance costs than Canadian counterparts
2011-08-04
ITHACA, N.Y. — U.S. physicians spend nearly $61,000 more than their Canadian counterparts each year on administrative expenses related to health insurance, according to a new study by researchers at Cornell University and the University of Toronto.
The study, published in the August issue of the journal Health Affairs, found that per-physician costs in the U.S. averaged $82,975 annually, while Ontario-based physicians averaged $22,205 – primarily because Canada's single-payer health care system is simpler.
Canadian physicians follow a single set of rules, but U.S. doctors ...
Group Health establishes major initiative to prevent opioid abuse and overdose
2011-08-04
SEATTLE—Fatal overdoses involving prescribed opioids tripled in the United States between 1999 and 2006, climbing to almost 14,000 deaths annually—more than cocaine and heroin overdoses combined. Hospitalizations and emergency room visits related to prescription opioid pain medicines such as oxycodone (brand name Oxycontin) and hydrocodone (Vicodin) also increased dramatically in the same period.
Now a report in the August issue of Health Affairs describes a major initiative at Group Health to make opioid prescribing safer while improving care for patients with chronic ...
Compression stockings may reduce OSA in some patients
2011-08-04
Wearing compression stockings may be a simple low-tech way to improve obstructive sleep apnea in patients with chronic venous insufficiency, according to French researchers.
"We found that in patients with chronic venous insufficiency, compression stockings reduced daytime fluid accumulation in the legs, which in turn reduced the amount of fluid flowing into the neck at night, thereby reducing the number of apneas and hypopnea by more than a third," said Stefania Redolfi, MD, of the University of Brescia in Italy, who led the research.
CVI occurs when a patient's veins ...
Gladstone scientist converts human skin cells into functional brain cells
2011-08-01
A scientist at the Gladstone Institutes has discovered a novel way to convert human skin cells into brain cells, advancing medicine and human health by offering new hope for regenerative medicine and personalized drug discovery and development.
In a paper being published online today in the scientific journal Cell Stem Cell, Sheng Ding, PhD, reveals efficient and robust methods for transforming adult skin cells into neurons that are capable of transmitting brain signals, marking one of the first documented experiments for transforming an adult human's skin cells into ...
Researchers target, switch off serotonin-producing neurons in mice
2011-08-01
Boston, MA (July 28, 2011) — Researchers have developed a toolkit that enables them to turn off targeted cell populations while leaving others unaffected.
Led by Susan Dymecki, a professor of genetics at Harvard Medical School, the group focused on serotonin-producing neurons, observing how mice behave in a normal environment when suddenly their serotonin neurons are turned down. While their findings affirm earlier studies, the researchers used a technique that is non-invasive and does not require anesthesia, surgeries, or knocking out a gene—each of which can cause ...